Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01106794 · ClinicalTrials.gov registry record
Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
A clinical trial of Diffuse Intrinsic Pontine Glioma and Brainstem Glioma, sponsored by Children's National Research Institute.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT01106794: Recruiting study of Diffuse Intrinsic Pontine Glioma and Brainstem Glioma, sponsored by Children's National Research Institute.
NCT01106794 is a study of Diffuse Intrinsic Pontine Glioma and Brainstem Glioma that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 100 participants, below the 132-participant average among 28 other Diffuse Intrinsic Pontine Glioma trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01106794, a study of Diffuse Intrinsic Pontine Glioma and Brainstem Glioma, is actively recruiting participants, sponsored by Children's National Research Institute.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to prospectively collect specimens from pediatric patients with diffuse intrinsic pontine glioma or brainstem glioma, either during therapy or at autopsy, in order to characterize the molecular abnormalities of this tumor.
Primary Outcome
Collected tumor and normal samples will potentially be used for RNA genome-wide expression pattern profiling.
Conditions Studied
Study Locations (1)
District of Columbia
- Children's National Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2010-04 |
| Est. Completion | 2030-04 |
What NCT01106794 shows while recruiting
NCT01106794 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 132-participant average among 28 other Diffuse Intrinsic Pontine Glioma trials with a reported enrollment target (24% lower).
The record links to 2 conditions, with Diffuse Intrinsic Pontine Glioma appearing as the primary indexed condition, and to 0 interventions.
NCT01106794 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT01106794 about?
NCT01106794 is a clinical study titled "Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma". The purpose of this study is to prospectively collect specimens from pediatric patients with diffuse intrinsic pontine glioma or brainstem glioma, either during therapy or at autopsy, in order to characterize the molecular abnormalities of this tumor.
What is the current status of trial NCT01106794?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2010-04. Estimated completion is 2030-04.
What conditions does trial NCT01106794 study?
This clinical trial studies the following conditions: Diffuse Intrinsic Pontine Glioma, Brainstem Glioma.
Who is sponsoring clinical trial NCT01106794?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01106794 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diffuse Intrinsic Pontine Glioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01106794's enrollment target sits among peer trials
100 9th of 28 higher than 20 of 28 other Diffuse Intrinsic Pontine Glioma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diffuse Intrinsic Pontine Glioma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
FUS Etoposide for DMG
RECRUITING · Phase 1
-
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RECRUITING · Early Phase 1
-
Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
RECRUITING · Phase 1
-
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RECRUITING · Phase 2
-
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
RECRUITING · Early Phase 1
-
Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia